Nov. 11, 2025
AMSTERDAM /PRNewswire/ — myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel the global expansion of myTomorrows’ integrated pharma solutions to make emerging treatments more equitable and accessible for patients globally.